nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Prothrombin level decreased—Docetaxel—head and neck cancer	0.0282	0.0282	CcSEcCtD
Fondaparinux sodium—Gastric irritation—Hydroxyurea—head and neck cancer	0.0268	0.0268	CcSEcCtD
Fondaparinux sodium—Bronchopneumonia—Docetaxel—head and neck cancer	0.0247	0.0247	CcSEcCtD
Fondaparinux sodium—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.0198	0.0198	CcSEcCtD
Fondaparinux sodium—Eruption—Hydroxyurea—head and neck cancer	0.0169	0.0169	CcSEcCtD
Fondaparinux sodium—Blister—Hydroxyurea—head and neck cancer	0.0144	0.0144	CcSEcCtD
Fondaparinux sodium—Bullous eruption—Docetaxel—head and neck cancer	0.0137	0.0137	CcSEcCtD
Fondaparinux sodium—Local reaction—Fluorouracil—head and neck cancer	0.0135	0.0135	CcSEcCtD
Fondaparinux sodium—Extravasation—Vinblastine—head and neck cancer	0.0131	0.0131	CcSEcCtD
Fondaparinux sodium—Cellulitis—Vinblastine—head and neck cancer	0.0125	0.0125	CcSEcCtD
Fondaparinux sodium—Tenderness—Hydroxyurea—head and neck cancer	0.0119	0.0119	CcSEcCtD
Fondaparinux sodium—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.011	0.011	CcSEcCtD
Fondaparinux sodium—Ulcer—Hydroxyurea—head and neck cancer	0.011	0.011	CcSEcCtD
Fondaparinux sodium—Creatinine increased—Hydroxyurea—head and neck cancer	0.0109	0.0109	CcSEcCtD
Fondaparinux sodium—Blister—Fluorouracil—head and neck cancer	0.0104	0.0104	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Hydroxyurea—head and neck cancer	0.00981	0.00981	CcSEcCtD
Fondaparinux sodium—Phlebitis—Vinblastine—head and neck cancer	0.0096	0.0096	CcSEcCtD
Fondaparinux sodium—Necrosis—Fluorouracil—head and neck cancer	0.00953	0.00953	CcSEcCtD
Fondaparinux sodium—Foetor hepaticus—Docetaxel—head and neck cancer	0.00951	0.00951	CcSEcCtD
Fondaparinux sodium—Tingling sensation—Fluorouracil—head and neck cancer	0.0093	0.0093	CcSEcCtD
Fondaparinux sodium—Eruption—Docetaxel—head and neck cancer	0.00878	0.00878	CcSEcCtD
Fondaparinux sodium—Tenderness—Fluorouracil—head and neck cancer	0.00857	0.00857	CcSEcCtD
Fondaparinux sodium—Extravasation—Fluorouracil—head and neck cancer	0.00857	0.00857	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00844	0.00844	CcSEcCtD
Fondaparinux sodium—Disorientation—Hydroxyurea—head and neck cancer	0.00843	0.00843	CcSEcCtD
Fondaparinux sodium—Cellulitis—Fluorouracil—head and neck cancer	0.00822	0.00822	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Hydroxyurea—head and neck cancer	0.00817	0.00817	CcSEcCtD
Fondaparinux sodium—Intestinal obstruction—Docetaxel—head and neck cancer	0.00792	0.00792	CcSEcCtD
Fondaparinux sodium—Liver disorder—Docetaxel—head and neck cancer	0.00792	0.00792	CcSEcCtD
Fondaparinux sodium—Ulcer—Fluorouracil—head and neck cancer	0.00791	0.00791	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00789	0.00789	CcSEcCtD
Fondaparinux sodium—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00784	0.00784	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00707	0.00707	CcSEcCtD
Fondaparinux sodium—Necrosis—Docetaxel—head and neck cancer	0.00688	0.00688	CcSEcCtD
Fondaparinux sodium—Sepsis—Fluorouracil—head and neck cancer	0.00649	0.00649	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00628	0.00628	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Vinblastine—head and neck cancer	0.00625	0.00625	CcSEcCtD
Fondaparinux sodium—Extravasation—Docetaxel—head and neck cancer	0.00619	0.00619	CcSEcCtD
Fondaparinux sodium—Swelling—Fluorouracil—head and neck cancer	0.00615	0.00615	CcSEcCtD
Fondaparinux sodium—Disorientation—Fluorouracil—head and neck cancer	0.00607	0.00607	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00594	0.00594	CcSEcCtD
Fondaparinux sodium—Oliguria—Docetaxel—head and neck cancer	0.00586	0.00586	CcSEcCtD
Fondaparinux sodium—Drug interaction—Docetaxel—head and neck cancer	0.00582	0.00582	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Hydroxyurea—head and neck cancer	0.00581	0.00581	CcSEcCtD
Fondaparinux sodium—Infestation—Hydroxyurea—head and neck cancer	0.00581	0.00581	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Vinblastine—head and neck cancer	0.00575	0.00575	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Vinblastine—head and neck cancer	0.00572	0.00572	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Vinblastine—head and neck cancer	0.00569	0.00569	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00568	0.00568	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Fluorouracil—head and neck cancer	0.00556	0.00556	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0055	0.0055	CcSEcCtD
Fondaparinux sodium—Hepatocellular injury—Docetaxel—head and neck cancer	0.0054	0.0054	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Hydroxyurea—head and neck cancer	0.00524	0.00524	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Hydroxyurea—head and neck cancer	0.00522	0.00522	CcSEcCtD
Fondaparinux sodium—Irritability—Fluorouracil—head and neck cancer	0.00518	0.00518	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Fluorouracil—head and neck cancer	0.00516	0.00516	CcSEcCtD
Fondaparinux sodium—Fluid retention—Docetaxel—head and neck cancer	0.00512	0.00512	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Docetaxel—head and neck cancer	0.00483	0.00483	CcSEcCtD
Fondaparinux sodium—Angiopathy—Hydroxyurea—head and neck cancer	0.00473	0.00473	CcSEcCtD
Fondaparinux sodium—Dysphagia—Fluorouracil—head and neck cancer	0.00469	0.00469	CcSEcCtD
Fondaparinux sodium—Sepsis—Docetaxel—head and neck cancer	0.00468	0.00468	CcSEcCtD
Fondaparinux sodium—Anaemia—Vinblastine—head and neck cancer	0.0046	0.0046	CcSEcCtD
Fondaparinux sodium—Phlebitis—Docetaxel—head and neck cancer	0.00455	0.00455	CcSEcCtD
Fondaparinux sodium—Vertigo—Vinblastine—head and neck cancer	0.00447	0.00447	CcSEcCtD
Fondaparinux sodium—Swelling—Docetaxel—head and neck cancer	0.00444	0.00444	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00432	0.00432	CcSEcCtD
Fondaparinux sodium—Convulsion—Vinblastine—head and neck cancer	0.00432	0.00432	CcSEcCtD
Fondaparinux sodium—Anaemia—Hydroxyurea—head and neck cancer	0.0042	0.0042	CcSEcCtD
Fondaparinux sodium—Hot flush—Docetaxel—head and neck cancer	0.00419	0.00419	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Fluorouracil—head and neck cancer	0.00418	0.00418	CcSEcCtD
Fondaparinux sodium—Infestation—Fluorouracil—head and neck cancer	0.00418	0.00418	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Docetaxel—head and neck cancer	0.00415	0.00415	CcSEcCtD
Fondaparinux sodium—Atrial fibrillation—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00412	0.00412	CcSEcCtD
Fondaparinux sodium—Renal impairment—Docetaxel—head and neck cancer	0.00412	0.00412	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Fluorouracil—head and neck cancer	0.0041	0.0041	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Docetaxel—head and neck cancer	0.0041	0.0041	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Fluorouracil—head and neck cancer	0.00407	0.00407	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Docetaxel—head and neck cancer	0.00402	0.00402	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Vinblastine—head and neck cancer	0.00398	0.00398	CcSEcCtD
Fondaparinux sodium—Epistaxis—Fluorouracil—head and neck cancer	0.00395	0.00395	CcSEcCtD
Fondaparinux sodium—Convulsion—Hydroxyurea—head and neck cancer	0.00394	0.00394	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Docetaxel—head and neck cancer	0.00392	0.00392	CcSEcCtD
Fondaparinux sodium—Anorexia—Vinblastine—head and neck cancer	0.00387	0.00387	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00384	0.00384	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Fluorouracil—head and neck cancer	0.00377	0.00377	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Fluorouracil—head and neck cancer	0.00376	0.00376	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00374	0.00374	CcSEcCtD
Fondaparinux sodium—Oedema—Hydroxyurea—head and neck cancer	0.00371	0.00371	CcSEcCtD
Fondaparinux sodium—Infection—Hydroxyurea—head and neck cancer	0.00368	0.00368	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Vinblastine—head and neck cancer	0.00365	0.00365	CcSEcCtD
Fondaparinux sodium—Dehydration—Docetaxel—head and neck cancer	0.00364	0.00364	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00364	0.00364	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00363	0.00363	CcSEcCtD
Fondaparinux sodium—Skin disorder—Hydroxyurea—head and neck cancer	0.0036	0.0036	CcSEcCtD
Fondaparinux sodium—Anorexia—Hydroxyurea—head and neck cancer	0.00353	0.00353	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Vinblastine—head and neck cancer	0.00353	0.00353	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00353	0.00353	CcSEcCtD
Fondaparinux sodium—Constipation—Vinblastine—head and neck cancer	0.00348	0.00348	CcSEcCtD
Fondaparinux sodium—Pain—Vinblastine—head and neck cancer	0.00348	0.00348	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00346	0.00346	CcSEcCtD
Fondaparinux sodium—Dysphagia—Docetaxel—head and neck cancer	0.00339	0.00339	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Fluorouracil—head and neck cancer	0.00336	0.00336	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Vinblastine—head and neck cancer	0.00335	0.00335	CcSEcCtD
Fondaparinux sodium—Bronchospasm—Docetaxel—head and neck cancer	0.00333	0.00333	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00332	0.00332	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Hydroxyurea—head and neck cancer	0.00331	0.00331	CcSEcCtD
Fondaparinux sodium—Somnolence—Hydroxyurea—head and neck cancer	0.0033	0.0033	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Hydroxyurea—head and neck cancer	0.00326	0.00326	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Hydroxyurea—head and neck cancer	0.00322	0.00322	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Vinblastine—head and neck cancer	0.00321	0.00321	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Fondaparinux sodium—Fatigue—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Fondaparinux sodium—Pain—Hydroxyurea—head and neck cancer	0.00317	0.00317	CcSEcCtD
Fondaparinux sodium—Constipation—Hydroxyurea—head and neck cancer	0.00317	0.00317	CcSEcCtD
Fondaparinux sodium—Vision blurred—Fluorouracil—head and neck cancer	0.00308	0.00308	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00305	0.00305	CcSEcCtD
Fondaparinux sodium—Anaemia—Fluorouracil—head and neck cancer	0.00302	0.00302	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Docetaxel—head and neck cancer	0.00302	0.00302	CcSEcCtD
Fondaparinux sodium—Infestation—Docetaxel—head and neck cancer	0.00302	0.00302	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Vinblastine—head and neck cancer	0.00299	0.00299	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00298	0.00298	CcSEcCtD
Fondaparinux sodium—Renal failure—Docetaxel—head and neck cancer	0.00297	0.00297	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Docetaxel—head and neck cancer	0.00296	0.00296	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Hydroxyurea—head and neck cancer	0.00293	0.00293	CcSEcCtD
Fondaparinux sodium—Asthenia—Vinblastine—head and neck cancer	0.00292	0.00292	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Fondaparinux sodium—Epistaxis—Docetaxel—head and neck cancer	0.00285	0.00285	CcSEcCtD
Fondaparinux sodium—Convulsion—Fluorouracil—head and neck cancer	0.00283	0.00283	CcSEcCtD
Fondaparinux sodium—Chest pain—Fluorouracil—head and neck cancer	0.00278	0.00278	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vinblastine—head and neck cancer	0.00278	0.00278	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00273	0.00273	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Docetaxel—head and neck cancer	0.00272	0.00272	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Docetaxel—head and neck cancer	0.00271	0.00271	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Docetaxel—head and neck cancer	0.0027	0.0027	CcSEcCtD
Fondaparinux sodium—Confusional state—Fluorouracil—head and neck cancer	0.00269	0.00269	CcSEcCtD
Fondaparinux sodium—Dizziness—Vinblastine—head and neck cancer	0.00269	0.00269	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Docetaxel—head and neck cancer	0.00267	0.00267	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00267	0.00267	CcSEcCtD
Fondaparinux sodium—Oedema—Fluorouracil—head and neck cancer	0.00267	0.00267	CcSEcCtD
Fondaparinux sodium—Asthenia—Hydroxyurea—head and neck cancer	0.00266	0.00266	CcSEcCtD
Fondaparinux sodium—Infection—Fluorouracil—head and neck cancer	0.00265	0.00265	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Fluorouracil—head and neck cancer	0.00262	0.00262	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00261	0.00261	CcSEcCtD
Fondaparinux sodium—Tachycardia—Fluorouracil—head and neck cancer	0.0026	0.0026	CcSEcCtD
Fondaparinux sodium—Vomiting—Vinblastine—head and neck cancer	0.00258	0.00258	CcSEcCtD
Fondaparinux sodium—Headache—Vinblastine—head and neck cancer	0.00255	0.00255	CcSEcCtD
Fondaparinux sodium—Anorexia—Fluorouracil—head and neck cancer	0.00254	0.00254	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Hydroxyurea—head and neck cancer	0.00254	0.00254	CcSEcCtD
Fondaparinux sodium—Flushing—Docetaxel—head and neck cancer	0.00252	0.00252	CcSEcCtD
Fondaparinux sodium—Hypotension—Fluorouracil—head and neck cancer	0.00249	0.00249	CcSEcCtD
Fondaparinux sodium—Angiopathy—Docetaxel—head and neck cancer	0.00246	0.00246	CcSEcCtD
Fondaparinux sodium—Dizziness—Hydroxyurea—head and neck cancer	0.00245	0.00245	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Docetaxel—head and neck cancer	0.00245	0.00245	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Docetaxel—head and neck cancer	0.00244	0.00244	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Fondaparinux sodium—Nausea—Vinblastine—head and neck cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Insomnia—Fluorouracil—head and neck cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Fluorouracil—head and neck cancer	0.0024	0.0024	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Fluorouracil—head and neck cancer	0.00238	0.00238	CcSEcCtD
Fondaparinux sodium—Somnolence—Fluorouracil—head and neck cancer	0.00237	0.00237	CcSEcCtD
Fondaparinux sodium—Malnutrition—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Fondaparinux sodium—Vomiting—Hydroxyurea—head and neck cancer	0.00236	0.00236	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Fluorouracil—head and neck cancer	0.00235	0.00235	CcSEcCtD
Fondaparinux sodium—Rash—Hydroxyurea—head and neck cancer	0.00234	0.00234	CcSEcCtD
Fondaparinux sodium—Dermatitis—Hydroxyurea—head and neck cancer	0.00234	0.00234	CcSEcCtD
Fondaparinux sodium—Headache—Hydroxyurea—head and neck cancer	0.00232	0.00232	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Fluorouracil—head and neck cancer	0.00232	0.00232	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0023	0.0023	CcSEcCtD
Fondaparinux sodium—Back pain—Docetaxel—head and neck cancer	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Pain—Fluorouracil—head and neck cancer	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Nausea—Hydroxyurea—head and neck cancer	0.0022	0.0022	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Fluorouracil—head and neck cancer	0.0022	0.0022	CcSEcCtD
Fondaparinux sodium—Anaemia—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Fondaparinux sodium—Urticaria—Fluorouracil—head and neck cancer	0.00212	0.00212	CcSEcCtD
Fondaparinux sodium—Syncope—Docetaxel—head and neck cancer	0.00212	0.00212	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Fluorouracil—head and neck cancer	0.00211	0.00211	CcSEcCtD
Fondaparinux sodium—Palpitations—Docetaxel—head and neck cancer	0.00209	0.00209	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Fondaparinux sodium—Cough—Docetaxel—head and neck cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Convulsion—Docetaxel—head and neck cancer	0.00204	0.00204	CcSEcCtD
Fondaparinux sodium—Chest pain—Docetaxel—head and neck cancer	0.00201	0.00201	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.002	0.002	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Fluorouracil—head and neck cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Confusional state—Docetaxel—head and neck cancer	0.00194	0.00194	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Docetaxel—head and neck cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Oedema—Docetaxel—head and neck cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Infection—Docetaxel—head and neck cancer	0.00191	0.00191	CcSEcCtD
Fondaparinux sodium—Shock—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Fondaparinux sodium—Pruritus—Fluorouracil—head and neck cancer	0.00189	0.00189	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Fondaparinux sodium—Tachycardia—Docetaxel—head and neck cancer	0.00188	0.00188	CcSEcCtD
Fondaparinux sodium—Skin disorder—Docetaxel—head and neck cancer	0.00187	0.00187	CcSEcCtD
Fondaparinux sodium—Anorexia—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Fluorouracil—head and neck cancer	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Hypotension—Docetaxel—head and neck cancer	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Dizziness—Fluorouracil—head and neck cancer	0.00176	0.00176	CcSEcCtD
Fondaparinux sodium—Insomnia—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Docetaxel—head and neck cancer	0.00173	0.00173	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Docetaxel—head and neck cancer	0.00172	0.00172	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—head and neck cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Vomiting—Fluorouracil—head and neck cancer	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Docetaxel—head and neck cancer	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Rash—Fluorouracil—head and neck cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Dermatitis—Fluorouracil—head and neck cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Headache—Fluorouracil—head and neck cancer	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Docetaxel—head and neck cancer	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Nausea—Fluorouracil—head and neck cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Docetaxel—head and neck cancer	0.00142	0.00142	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—head and neck cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Pruritus—Docetaxel—head and neck cancer	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Docetaxel—head and neck cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Dizziness—Docetaxel—head and neck cancer	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Vomiting—Docetaxel—head and neck cancer	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Rash—Docetaxel—head and neck cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—head and neck cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—head and neck cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Nausea—Docetaxel—head and neck cancer	0.00114	0.00114	CcSEcCtD
